| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.1M | +17.5% |
| R&D Expense | $18.2M | +18.6% |
| SG&A Expense | $6.8M | +6.3% |
| Operating Income | -$18.9M | +6.0% |
| Net Income | -$18.8M | +6.6% |
| EPS (Basic) | -$5.46 | +36.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.6M | -33.8% |
| Accounts Receivable | $1.3M | +1837.3% |
| Current Assets | $38.1M | -30.4% |
| Total Assets | $41.0M | -30.4% |
| Current Liabilities | $5.0M | +13.1% |
| Total Liabilities | $9.8M | -13.4% |
| Stockholders' Equity | $31.1M | -34.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | +1.9% |
| Capital Expenditures | $86K | -40.3% |
| Investing Cash Flow | -$86K | +40.3% |
| Financing Cash Flow | $1.2M | -97.2% |
| Free Cash Flow | -$19.4M | +2.2% |